The main purpose of this study is to use an investigational urine assay to estimate the proportion of pneumonia in adults 50 years or older in different areas throughout the US that is caused by certain types of the bacteria Streptococcus pneumoniae (also called pneumococcus).
Study Type
OBSERVATIONAL
Enrollment
782
All subjects have non-invasive urine sample collection performed
University of South Alabama Division of Clinical Research
Mobile, Alabama, United States
Sharpe-Grossmont Hospital
La Mesa, California, United States
Proportion of subjects who have vaccine-type (VT), ie, PCV13, S. pneumoniae.
Time frame: 6-12 months
Proportion of subjects with VT-type pneumonia by previous healthcare facility exposure status will be described by site.
Time frame: 6-12 months
Proportion of subjects with detection of S. pneumoniae by culture, BinaxNOW, and UAD assay will be summarized by method.
Time frame: 6-12 months
Serotype distribution of S. pneumoniae cases by site and across all sites.
Time frame: 6-12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Tampa General Hospital
Tampa, Florida, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
Baystate Infectious Diseases Clinical Research
Springfield, Massachusetts, United States
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States
Detroit Receiving Hospital
Detroit, Michigan, United States
Sinai Grace Hospital
Detroit, Michigan, United States
eStudySite
Las Vegas, Nevada, United States
...and 4 more locations